Premier Healthcare

Patient Portal






Accountable Care Organization (ACO)

Quality Performance Report 2012 - 2014:

2012 Reporting Period 2013 Reporting Period 2014 Reporting Period
Measure Number Performance Measures ACO Performance Rate Mean performance for all ACOs ACO Performance Rate Mean performance for all ACOs ACO Performance Rate Mean performance for all ACOs
ACO #1 Getting Timely Care, Appointments, and Information 79.42 80.13
ACO #2 How Well Your Doctors Communicate 94.63 92.39
ACO #3 Patients' Rating of Doctor 94.86 91.58
ACO #4 Access to Specialists 84.59 83.97
ACO #5 Health Promotion and Education 54.54 58.29
ACO #6 Shared Decision Making 74.60 74.60
ACO #7 Health Status/Functional Status 70.44 71.10
ACO #8 Risk Standardized, All Condition Readmissions 13.88 14.90 13.67 15.15
ACO #9 ASC Admissions: COPD or Asthma in Older Adults 0.94 1.17 1.05 1.08
ACO #10 ASC Admission: Heart Failure 0.68 1.20 0.64 1.19
ACO #11 Percent of PCPs who Qualified for EHR Incentive Payment 80.77% 66.21% 92.00% 76.71
ACO #12 Medication Reconciliation 37.50% 82.61
ACO #13 Falls: Screening for Fall Risk 40.00% 45.60
ACO #14 Influenza Immunization 55.34% 57.51
ACO #15 Pneumococcal Vaccination 49.50% 55.03
ACO #16 Adult Weight Screening and Follow-up 63.77% 66.75
ACO #17 Tobacco Use Assessment and Cessation Intervention 94.10% 86.79
ACO #18 Depression Screening 57.45% 39.27
ACO #19 Colorectal Cancer Screening 66.33% 56.14
ACO #20 Mammography Screening 30.25% 61.41
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years 82.90% 60.24
ACO #22 Hemoglobin A1c Control (HbA1c) (<8 percent) 76.61% N/A
ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) 65.76% N/A
ACO #24 Blood Pressure (BP) <140/90 71.69% N/A
ACO #25 Tobacco Non Use 86.61% N/A
ACO #26 Aspirin Use 100.00% N/A
ACO #27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) 9.34% 20.35
ACO #28 Percent of beneficiaries with hypertension whose BP <140/90 68.53% 68.02
ACO #29 Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl N/A N/A
ACO #30 Percent of beneficiaries with IVD who use Aspirin or other antithrombotic 84.18% 80.79
ACO #31 Beta-Blocker Therapy for LVSD 90.00% 82.71
ACO #32 Drug Therapy for Lowering LDL Cholesterol N/A N/A
ACO #33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD 76.38% N/A
ASC = Ambulatory Sensitive Conditions, COPD = Chronic Obstuctive Pulmonary Disease, EHR = Electronic Health Record, IVD = Ischemic Vascular Disease, LVSD = Left Ventricular Systolic Dysfunction, ACE = Angiotensin-Converting Enzyme, ARB = Angiotensin Receptor Blocker, CAD = Coronary Artery Disease.